Vardenafil & Tadalafil — PDE5 Inhibitor Therapy
ED affects 1 in 3 men over 40 and is one of the most under-treated conditions in medicine. Not because there's no solution — but because most men never ask. ILSA Health makes it simple, private, and clinically sound. Vardenafil for fast, reliable performance. Tadalafil for daily, always-ready confidence.
Erectile dysfunction is one of the most common and least discussed medical conditions affecting men. Shame, stigma, and the assumption that "it just happens with age" prevent most men from seeking treatment that works — and works well.
Erection requires adequate blood flow to penile tissue — dependent on healthy endothelial function. Hypertension, atherosclerosis, metabolic syndrome, and smoking all impair the vascular response that makes erection possible.
Testosterone drops roughly 1% per year after 30. Low T directly reduces libido, impairs erection quality, and diminishes sexual confidence — a cascade that compounds the psychological burden of ED.
One failed encounter can create a self-reinforcing anxiety loop — fear of failure becomes the cause of failure. Psychological ED is as real as physiological ED, and the treatment interrupts both cycles simultaneously.
SSRIs, antihypertensives, statins, and dozens of common medications list ED as a direct side effect. Most men are never told — and most doctors don't proactively manage it. PDE5 therapy safely addresses medication-induced ED in most cases.
Untreated ED doesn't stay in the bedroom. It erodes intimacy, creates distance between partners, and compounds into anxiety, depression, and withdrawal. Treating ED treats the relationship — not just the symptom.
Most men with ED never speak to a doctor about it. The barrier isn't clinical — it's the conversation. ILSA Health eliminates it entirely: assessment online, prescription reviewed remotely, treatment shipped to your door. No waiting room.
"ED affects 1 in 3 men over 40.
Nearly all of them can be effectively treated. Most never try."
Both medications are clinically proven, FDA-approved PDE5 inhibitors. The difference is timing, duration, and lifestyle fit — not effectiveness.
Both Vardenafil and Tadalafil work by inhibiting phosphodiesterase type 5 — the enzyme that breaks down cGMP, the signaling molecule responsible for smooth muscle relaxation and vasodilation in penile tissue. Here's what that means in practice.
Sexual stimulation triggers nitric oxide release in penile tissue, which produces cGMP — the molecule that relaxes smooth muscle and allows blood to fill the corpus cavernosum. PDE5 degrades cGMP prematurely. Both medications block PDE5, allowing cGMP to accumulate and vasodilation to occur and sustain normally.
PDE5 inhibitors do not cause erections independently. Sexual arousal is still required to initiate the nitric oxide cascade. The medication simply ensures that once triggered, the physiological response is complete and sustained — removing the vascular failure point without affecting libido or sensation.
Vardenafil has approximately 10× greater selectivity for PDE5 over PDE6 (retinal) and PDE1 (cardiac) compared to sildenafil, producing fewer visual and cardiovascular side effects. It also reaches peak plasma concentration faster — often effective within 25 minutes in fasting conditions.
Tadalafil has a plasma half-life of 17.5 hours — roughly 3–4× longer than other PDE5 inhibitors. This enables both as-needed 36-hour coverage and effective daily low-dose (5mg) therapy that maintains continuous baseline PDE5 inhibition, eliminating performance timing entirely.
PDE5 inhibitor therapy is among the most clinically validated treatments in men's health. Here's what the data consistently shows across thousands of patients.
Clinical trials document successful sexual intercourse in the vast majority of men treated with PDE5 inhibitors — across mild, moderate, and severe ED presentations.
Among men who complete a full course of treatment, satisfaction with sexual function, confidence, and relationship quality is consistently high — with the majority continuing long-term.
Most patients experience clinical effect within 30–60 minutes. Vardenafil can be effective in as little as 25 minutes under fasting conditions — faster than any other PDE5 inhibitor in the class.
Consistent, clinically supported erectile function — not luck, not willpower. A physiological response you can rely on, produced by the body's own mechanisms freed from vascular failure.
Performance anxiety breaks its own loop. When function is reliable, the psychological weight of anticipated failure lifts — often permanently, even beyond the medication window.
Intimacy returns. Distance that accumulated around untreated ED begins to close. Partners report as much improvement in relationship satisfaction as patients themselves.
Daily Tadalafil eliminates the need to plan around a medication window — restoring the natural, unscheduled intimacy that defines a healthy sexual relationship.
Fast onset, potent effect, and minimal dietary interference make Vardenafil the precision tool — reliable performance in as little as 25 minutes from a single dose.
Tadalafil is the only PDE5 inhibitor FDA-approved for benign prostatic hyperplasia (BPH). Daily dosing simultaneously improves urinary flow — addressing two of the most common men's health conditions with one medication.
The psychological relief of treated ED has measurable effects on depression, self-esteem, and overall wellbeing. Men report feeling more like themselves — in and out of the bedroom.
No pharmacy counter. No waiting room. No conversation you didn't choose to have. Assessment online, prescription reviewed remotely, medication shipped directly. Complete control over your health information.
No waiting rooms. No uncomfortable conversations. The entire process happens online — from assessment to prescription to door. A licensed U.S. provider reviews your case within 24–48 hours.
Answer structured health questions privately online. Takes about 10 minutes. 100% confidential.
A licensed U.S. provider evaluates your case, determines the appropriate medication and dose within 24–48 hours.
Your 503A pharmacy compounds your medication to prescription specifications.
Shipped in plain, unmarked packaging to your door. No indication of contents. Complete privacy maintained.
Your health information is fully protected under federal HIPAA regulations. It is never shared, sold, or disclosed without your explicit consent.
All orders ship in plain, unmarked packaging with no indication of sender or contents. Your mailbox tells no one what you ordered.
The entire process — assessment, prescription review, pharmacy fulfillment — happens online. You never have to have a conversation you didn't choose.
Vardenafil and Tadalafil are available by prescription only and require licensed provider evaluation. These medications are contraindicated with nitrate medications and in patients with certain cardiovascular conditions — your provider will screen for these during assessment. Individual results vary. Compounded medications are not FDA-approved. ILSA Health does not manufacture or compound medications — all prescriptions are fulfilled by independent U.S.-licensed 503A pharmacies. Completion of an assessment does not guarantee approval or create a physician–patient relationship.
Ready to Start
Complete your private assessment online. A licensed U.S. provider will review your case within 24–48 hours. Medication ships directly to your door in discreet packaging. From $79/month — provider review included.
Start Your Private Assessment
The health assessment offered through ILSA Health is designed for preliminary screening and educational purposes only. Completion of this questionnaire does not create a doctor–patient relationship.
All medical services, including clinical evaluations, treatment plans, and prescription decisions, are provided exclusively by independent U.S.-licensed healthcare providers. Providers exercise full medical judgment and determine eligibility based on individual clinical assessment and applicable state regulations.
If approved, prescriptions are dispensed by U.S.-based 503A compounding pharmacies that are registered with the FDA and operate in compliance with United States Pharmacopeia standards. Compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness, or manufacturing consistency.
Individual responses to treatment vary. No specific results are guaranteed.
ILSA Health does not manufacture, compound, or directly dispense medications. Product appearance, packaging, and labeling may vary from images shown on this website.
All trademarks and product names are the property of their respective owners.
GET SUPPORT
Email: [email protected]
Phone: 754 227 9 227
Phone: 754 227 9 227
1600 S Dixie HWY, Suite 108,
Boca Raton FL 33432




Home
Home
Home
Home
Home
Home
Personalized Tirzepatide
Personalized Semaglutide
FAQ
Tirzepatide Safety Information
Semaglutide Safety Information
Login
Get Started
Referral Program
© Ilsa Health - 2026 All Rights Reserved
Clinic Designed By: Med Clinic Auhtority